Actinomyces naeslundii Thompson and Lovestedt (ATCC® 12104)

Strain Designations: 279 [CDC W826, NCTC 10301]  /  Type Strain: yes  /  Biosafety Level: 2

Strain Designations 279 [CDC W826, NCTC 10301]
Isolation
Human sinus
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Type Strain yes
Medium ATCC® Medium 1490: Modified chopped meat medium
Growth Conditions
Temperature: 37°C
Atmosphere: Anaerobic gas mixture, 80% N2-10% CO2-10% H2
Name of Depositor A Howell
Chain of Custody
ATCC <-- A Howell <-- L. Thompson
Isolation
Human sinus
References

Georg LK, et al. Identification of species of Actinomyces. J. Bacteriol. 88: 477-490, 1964. PubMed: 14203367

Thompson L, Lovestedt SA. An actinomyces-like organism obtained from the human mouth. Proc. Staff Meet. Mayo Clin. 26: 169-175, 1951.

Coleman RM, et al. Actinomyces naeslundii as an agent of human actinomycosis. Appl. Microbiol. 18: 420-426, 1969. PubMed: 4907004

Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980.

Cross References

Nucleotide (GenBank) : M21976 A.naeslundii type 2 fimbriae subunit gene, complete cds.

Nucleotide (GenBank) : AF058052 Actinomyces naeslundii 16S ribosomal RNA gene, partial sequence.

Nucleotide (GenBank) : AF228582 Actinomyces naeslundii fructosyltransferase (ftf) gene, complete cds.